Astellas Pharma Inc. (4503)

2,197.0 +34.0 (+1.57%)
Close JPY Disclaimer

4503 Earnings

Title
Quarterly
Annually
Latest Release Apr 27, 2022 Mar 31, 2022
EPS
16 22.73
67.05
Revenue
303.9B 323.01B
1,296.16B
Next release Date Jul 29, 2022 -
Expected growth 41.38% -
Clear All
0Selected
Please try another search
EPS
Revenue
Historical Earnings
EPS
Revenue
Forecast
Release Date
Period End
EPS Actual
EPS Forecast
EPS Surprise
Revenue Actual
Revenue Forecast
Revenue Surprise
Jul 29, 2022 06/2022 -- 22.62 -22.62 -- 345.58B -345.58
Apr 27, 2022 03/2022 16 22.73 -6.73 303.9B 323.01B -19.11
Feb 02, 2022 12/2021 32.86 33.64 -0.78 340.63B 349.59B -8.96
Oct 29, 2021 09/2021 22.09 27.03 -4.94 325.52B 330.61B -5.09
Jul 30, 2021 06/2021 16.56 24.93 -8.37 326.14B 317.24B +8.9
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles